Cargando…
Apolipoprotein A-I and Cancer
High-density lipoprotein (HDL) and apolipoprotein A-I (apoA-I), the predominant protein in plasma HDL, have long been the focus of intense studies in the field of atherosclerosis and cardiovascular disease. ApoA-I, in large part, is responsible for HDL assembly and its main atheroprotective function...
Autores principales: | Zamanian-Daryoush, Maryam, DiDonato, Joseph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642354/ https://www.ncbi.nlm.nih.gov/pubmed/26617517 http://dx.doi.org/10.3389/fphar.2015.00265 |
Ejemplares similares
-
Apolipoprotein A-I anti-tumor activity targets cancer cell metabolism
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2020) -
Abnormal levels of apolipoprotein A-I in chronic thromboembolic pulmonary hypertension
por: Khirfan, Ghaleb, et al.
Publicado: (2021) -
Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo
por: Iqbal, Asif J, et al.
Publicado: (2016) -
Importance of Apolipoprotein A-I in Multiple Sclerosis
por: Gardner, Lidia A., et al.
Publicado: (2015) -
Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2017)